Kim L Wilkerson, NP-C | |
404 W Fountain St, Albert Lea, MN 56007-2437 | |
(507) 369-5314 | |
Not Available |
Full Name | Kim L Wilkerson |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 16 Years |
Location | 404 W Fountain St, Albert Lea, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558510693 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Health System - Albert Lea And Austin | Albert lea, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
Two teams of scientists working half a world apart, have identified what they believe is a simple, effective and inexpensive treatment to reduce lung problems associated with cystic fibrosis.
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.
Scientists from four well-known institutions say the next major disease like HIV/AIDS or SARS could occur in any of a number of developing countries concentrated along the equator.
Emergent BioSolutions Inc. today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion's Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to novel and versatile protein therapeutic platforms.
› Verified 2 days ago
Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
Two teams of scientists working half a world apart, have identified what they believe is a simple, effective and inexpensive treatment to reduce lung problems associated with cystic fibrosis.
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.
Scientists from four well-known institutions say the next major disease like HIV/AIDS or SARS could occur in any of a number of developing countries concentrated along the equator.
Emergent BioSolutions Inc. today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion's Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to novel and versatile protein therapeutic platforms.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Kim L Wilkerson, NP-C 618 Park Ave, Albert Lea, MN 56007-4435 Ph: (507) 369-5314 | Kim L Wilkerson, NP-C 404 W Fountain St, Albert Lea, MN 56007-2437 Ph: (507) 369-5314 |
News Archive
Two teams of scientists working half a world apart, have identified what they believe is a simple, effective and inexpensive treatment to reduce lung problems associated with cystic fibrosis.
AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.
Scientists from four well-known institutions say the next major disease like HIV/AIDS or SARS could occur in any of a number of developing countries concentrated along the equator.
Emergent BioSolutions Inc. today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion's Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to novel and versatile protein therapeutic platforms.
› Verified 2 days ago
Megan Thompson, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Richard Lyle Wood, RN CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Minji Na, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2708 Bridge Ave, Albert Lea, MN 56007 Phone: 507-377-6285 | |
Rebekah Mowers, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Shaina Rae Watson, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 | |
Sheila Calderon, CNP, FNP, RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 323 Willamor Cir, Albert Lea, MN 56007 Phone: 507-951-6957 | |
Andrea Nicholson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 |